CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Read more about CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Read more about Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Read more about Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Read more about TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Read more about Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Read more about LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition. Read more about Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Read more about Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.
Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Read more about Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.
Subgroup-specific alternative splicing in medulloblastoma. Read more about Subgroup-specific alternative splicing in medulloblastoma.
